|
Date: |
October 6-7, 2008 |
|
Location: |
New York, NY - USA |
|
Organizer: |
Alzheimer's Drug
Discovery Foundation
www.alzdiscovery.org
|
|
Venue: |
Westin New York @ Times Square |
|
Conference Structure: |
Lectures, Q&A/Panel Discussions,
Exhibits, Networking Events |
|
Conference Chair: |
Howard Fillit, MD -
Executive Director,
Alzheimer's Drug
Discovery Foundation |
|
Target Audience: |
The 2007
edition of this conference generated an
overwhelming response,
attracting over 150 attendees
from around the globe.
Attendees include:
- Academic and industry
scientists engaged in
drug discovery research
for neurodegenerative
diseases or CNS
- Business development
and licensing
professionals
- Alliance management
professionals
- Venture capitalists
and other investors |
|
Objectives: |
 The conference will
bring together academic
and industry scientists
to accelerate the
development of novel
drug discovery programs
for Alzheimer’s disease.
It will offer updates on
ongoing research, as
well as highlight new
studies and concepts.
This ADDF meeting is
one of the few
conferences that
focuses exclusively on the
development of
innovative drugs
targeting
Alzheimer's disease
and related
dementias.
Conference
objectives:
-
To
discuss scientific progress
on drug discovery programs
aimed at treating
Alzheimer’s disease and
related dementias.
-
To increase networking
opportunities for scientists
to share information and
resources.
-
To publish and distribute a
post-meeting report in a
peer-reviewed scientific
journal. |
|
Language: |
The official language of
the meeting is English.
|
|
Dress: |
The dress for the
meeting is business
casual. |
|
Liability: |
The meeting organizers
and the secretariat will
not accept liability for
any personal injury,
damage or loss that may
occur during or directly
arising from this
meeting. |
|
Conference
Secretariat: |
World Events Forum,
Inc.
5030 N Marine Drive,
Suite 2608
Chicago, IL 60640
- USA
+1.773.784.8134
(tel)
+1.208.575.5453
(fax)
top
|
